期刊文献+

姜黄素对乳腺癌细胞VEGF-C表达及增殖、侵袭性的影响 被引量:15

Effect of Curcumin on VEGF-C Expression,Proliferation and Invasion of Breast Cancer Cell
下载PDF
导出
摘要 目的探讨姜黄素对乳腺癌MCF-7细胞的增殖、侵袭性及VEGF-C表达的影响。方法 MTT法,Transwell小室检测姜黄素对MCF-7细胞增殖和侵袭性的影响;RT-PCR、Western blot方法检测姜黄素作用MCF-7细胞前后VEGF-C mRNA及蛋白水平表达的变化。结果姜黄素能有效抑制乳腺癌MCF-7细胞增殖,其IC50为37μmol/L,随浓度增高其抑制作用增强(P<0.05),同时降低乳腺癌MCF-7细胞的侵袭性(P<0.001)。不同浓度姜黄素可降低MCF-7细胞VEGF-C mRNA及蛋白水平的表达(P<0.05),40μmol/L组比20μmol/L组下降明显(P<0.05)。结论姜黄素可以抑制乳腺癌MCF-7细胞的增殖及侵袭性,其机制可能是通过下调VEGF-C的表达。 Objective To evaluate the effects of curcumin on proliferation, invasion and VEGF-C expres- sion in human breast cancer cell lines MCF-7. Methods Proliferation and invasion of MCF-7 cell inhibited by curcumin were assessed by MTT and Transwell technique. Expression levels of VEGF-C mRNA and protein in MCF-7 cell were determined by reverse transcription polymerase chain reaction(RT-PCR)and Western blot respectively. Results The Curcumin markedly inhibited proliferation capacity of MCF-7 cell (P〈0. 001 ). The half maximal inhibitory concentration (ICso) was 37/μmol/L. The number of invasion of MCF-7 cell were significantly lower in curcumin group than that in control group(P〈0. 001). It was also lower in 40/μmol/L group than 20/μmol/L group(P%0. 001). VEGF-C mRNA and protein expres- sion were also effectively down regulated in vitro. The relative expression of VEGF-C mRNA and protein were lower in 40/μmol/L group than 20 μmol/L group(P〈0.05). Conclusion The proliferation and invasion ability of MCF-7 cell is effectively inhibited by curcumin. It is possible to inhibit the invasion of MCF-7 cell by down-regulation of VEGF-C expression.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第10期1109-1112,共4页 Cancer Research on Prevention and Treatment
基金 江西省卫生厅中医药科研基金资助项目(2007A058)
关键词 姜黄素 乳腺癌 VEGF-C 侵袭性 Curcumin Human breast cancer VEGF-C Invasion
  • 相关文献

参考文献17

  • 1Jemal A,Siegel R,Ward E,et al.Cancer statistics,2008[J].CA Cancer J Clin,2008,58(2):71-96.
  • 2Ziegler RG,Anderson WF,Gail MH.Increasing breast cancer incidence in China the numbers add up[J].J Natl Cancer Inst,2008,100(19):1339-1341.
  • 3郭小毛,梅欣,章倩.局部晚期乳腺癌的治疗进展[J].中国癌症杂志,2006,16(6):409-416. 被引量:35
  • 4Narasimhan M,Ammanamanchi S.Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells[J].Cancer Res, 2008,68(13):5185-5192.
  • 5Epstein J, Sanderson IR, Macdonald TT.Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies[J]. Br J Nutr,2010, 103(11):1545-1557.
  • 6Sun JG,Wang Y,Chen ZT,et al.Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value[J].J Exp Clin Cancer Res,2009,28:21.
  • 7Gu Y,Qi X,Guo S.Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: a retrospective study of 61 cases[J].Clin Exp Metastasis,2008,25 (7):717-725.
  • 8Li JL,Harris AL.Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications[J].Front Biosci,2009,14:3094-3110.
  • 9Su JL,Yen CJ, Chen PS,et al.The role of the VEGF-C/VEGFR-3 axis in cancer progression[J].Br J Cancer,2007,96(4):541-545.
  • 10Masood R, Kundra A, Zhu S,et al.Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops[J].Int J Cancer ,2003,104(5): 603-610.

二级参考文献42

  • 1季艳霞,姜达,康振桥.沙立度胺对人乳腺癌细胞增殖及血管内皮生长因子表达的影响[J].肿瘤学杂志,2005,11(1):26-28. 被引量:7
  • 2张聚良,王岭,凌瑞,姚青.VEGF-C在乳腺癌组织中的表达及临床意义[J].现代肿瘤医学,2005,13(4):477-479. 被引量:6
  • 3Fisher ER,Wang J,Bryant J,et al.Pathobiology of preoperative chemotherapy:findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18[J].Cancer,2002,95(4):681-695.
  • 4Abraham DC,Jones RC,Jones SE,et al.Evaluating of neoadjuvant chemoterhapeutic response of locally advanced breast cancer by magnetic resonace imaging[J].Cancer,1996,78(1):91-100.
  • 5Haagensen CD,Stout AP.Carcinoma of breast:criteria of in operability[J].Am Surg,1943,118:859.
  • 6Bonadonna G,Veronesi U,Brambilli C,et al.Primary chemotherapy to avoidmastectomy in tumors with diameters or three centimeters of more[J].J Natl Cancer Inst,1990,82(19):1539-1545.
  • 7Fisher B,Guiduz N,Saffer EA.Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases[J].Cancer Res,1983,43(4):1488-1492.
  • 8Hana han D,Folkman J.Patterns and cmerging mechanisms of the angiogenic swith during tumorigenesis[J].Cell,1996,86(3):353-364.
  • 9Makris A,Powles TJ,Lakolyris S,et al.Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in pastients with operable breast carcinoma[J].Cancer,1999,85(9):1996-2000.
  • 10Kuerer HM,Newman LA,Buzder AU,et al.Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer[J].Am J Surg,1998,176(6):502-509.

共引文献37

同被引文献261

引证文献15

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部